DNAI1

DNAI1 encodes an axonemal dynein intermediate chain that is essential for the assembly of outer dynein arms (ODAs) in motile cilia and flagella; loss of the Chlamydomonas ortholog ODA6 prevents assembly of all major outer arm dynein subunits (PMID:1673970). Compound heterozygous loss-of-function mutations in DNAI1 cause primary ciliary dyskinesia (PCD), with or without situs inversus, accounting for approximately 7–10% of PCD cases and segregating exclusively with ODA-defective phenotypes (PMID:11231901, PMID:16858015). DNAI1 also participates in oligogenic epistatic interactions with other ODA components such as DNAH6, whereby trans-heterozygous perturbation of both genes disrupts cilia-driven left-right patterning and causes heterotaxy (PMID:26918822).

1. 1991 High

   The identity of the gene encoding the 70 kDa ODA intermediate chain was established: Chlamydomonas ODA6, the DNAI1 ortholog, was shown to be absolutely required for stable outer dynein arm assembly, answering whether a single intermediate chain is sufficient for ODA biogenesis.

   Evidence Genetic rescue of oda6 mutant Chlamydomonas by transformation with wild-type genomic clone; complementation and RFLP mapping

   PMID:1673970

   Open questions at the time

   • Whether the human ortholog performs an identical role was not yet tested
   • Mechanism by which the intermediate chain scaffolds other ODA subunits was not resolved
   • No structural model for intermediate chain–heavy chain interaction
2. 2001 High

   The first direct genetic link between human DNAI1 and disease was established: compound heterozygous mutations in DNAI1 cause primary ciliary dyskinesia with or without situs inversus, demonstrating that the ODA intermediate chain is essential for ciliary motility and left-right axis determination in humans.

   Evidence Sequencing of DNAI1 in PCD/Kartagener syndrome patients; identification of compound heterozygous mutations including a shared splice defect allele across families

   PMID:11231901

   Open questions at the time

   • Mutation frequency and allelic spectrum across diverse populations were unknown
   • Whether DNAI1 mutations could cause ciliary defects beyond the ODA phenotype was unclear
3. 2006 High

   Large-cohort sequencing defined the contribution and allelic architecture of DNAI1 in PCD: DNAI1 mutations account for ~9–10% of cases, with the founder allele IVS1+2_3insT predominating, and mutations segregate exclusively with ODA defects, confirming DNAI1 is dispensable when ODA structure is intact.

   Evidence Full coding region sequencing in 179 unrelated PCD families; RT-PCR on nasal epithelial RNA; haplotype analysis

   PMID:16858015

   Open questions at the time

   • Contribution of large structural rearrangements to DNAI1 pathogenesis had not been assessed
   • Genotype–phenotype correlations for specific missense variants were limited
4. 2016 Medium

   The discovery of oligogenic epistasis between DNAI1 and DNAH6 expanded the mechanistic model from simple Mendelian loss-of-function to combinatorial dosage sensitivity: trans-heterozygous reduction of both ODA components disrupts cilia-driven laterality, explaining some heterotaxy cases without biallelic mutations in a single gene.

   Evidence Subthreshold double morpholino knockdown in zebrafish; siRNA knockdown in heterozygous Dnai1 mutant mouse respiratory epithelia with cilia beat analysis

   PMID:26918822

   Open questions at the time

   • Physical interaction between DNAI1 and DNAH6 proteins was not demonstrated biochemically
   • Whether DNAI1 engages in epistatic interactions with additional ODA or IDA genes is untested
   • Morpholino-based evidence in zebrafish requires genetic confirmation

• The precise mechanism by which DNAI1 scaffolds or chaperones ODA heavy and light chains during cytoplasmic pre-assembly and axonemal docking remains structurally unresolved, and the full epistatic network governing DNAI1-dependent left-right patterning is incomplete.
• No high-resolution structural model of DNAI1 within the ODA complex
• Cytoplasmic pre-assembly and transport mechanism of DNAI1-containing ODA subcomplexes not characterized
• Complete set of oligogenic partners modifying DNAI1-associated phenotypes is unknown